How effective is Fosamax for Osteoporosis? (a real world drug study)
Summary:
Overall ratings: 2.7/5 Long term ratings: 2.8/5
This is a phase IV clinical study of how effective Fosamax (alendronate sodium) is for Osteoporosis and for what kind of people. The study is created by eHealthMe from 161 Fosamax users and is updated continuously.
What is Fosamax?
Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,813 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.
161 people are studied for taking Fosamax in Osteoporosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Fosamax effectiveness for Osteoporosis (number of people):
Overall:
- not at all: 20
- somewhat: 44
- moderate: 64
- high: 27
- very high: 6
Long Term:
- not at all: 8
- somewhat: 31
- moderate: 48
- high: 21
- very high: 2
Gender of people who take Fosamax for Osteoporosis *:
- female: 86.96 %
- male: 13.04 %
Age of people who take Fosamax for Osteoporosis *:
- 0-1: 0.62 %
- 2-9: 0.0 %
- 10-19: 1.24 %
- 20-29: 0.62 %
- 30-39: 1.24 %
- 40-49: 6.83 %
- 50-59: 21.12 %
- 60+: 68.32 %
Who find Fosamax more effective for Osteoporosis?
Gender of people who take Fosamax for Osteoporosis *:
- female: 87.88 %
- male: 12.12 %
Age of people who take Fosamax for Osteoporosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 6.06 %
- 20-29: 3.03 %
- 30-39: 3.03 %
- 40-49: 12.12 %
- 50-59: 18.18 %
- 60+: 57.58 %
* Approximation only. Some reports may have incomplete information.
Do you take Fosamax?
- You can start a phase IV clinical trial to monitor Fosamax safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Fosamax (105,452 reports)
Treatments, associated drugs and conditions:
- Osteoporosis (290,734 reports)
How the study uses the data?
The study is based on alendronate sodium (the active ingredients of Fosamax) and Fosamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lisinopril and Combivir - now
- Drug interactions of Kenalog and Iodine - 12 seconds ago
- Labetalol Hydrochloride vs. Isoptin, side effect and effectiveness comparison - 12 seconds ago
- Drug interactions of Profen and Docosahexanoic Acid - 13 seconds ago
- Could Vicodin cause Pelvic Pain? - 14 seconds ago
- Could Hydrochlorothiazide cause Movement - Uncoordinated? - 16 seconds ago
- Drug interactions of Norfloxacin and Micafungin - 47 seconds ago
- Drug interactions of Bromfenac Sodium and Carvedilol - a minute ago
- Could Remeron cause Nervous System Disorder? - a minute ago
- Drug interactions of Albuterol and Precedex - a minute ago